Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency

Metabolism: Clinical and Experimental

Volumn 46, Issue 9, 1997, Pages 1024-1031

  Marescau, Bart ^a   Nagels, Guy ^b   Possemiers, Ilse ^b   De Broe, Marc E ^b   Becaus, Ignace ^b   Billiouw, Jean Marie ^b   Lornoy, Willy ^b   De Deyn, Peter P ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GUANIDINE DERIVATIVE; GUANIDINOACETIC ACID; GUANIDINOSUCCINIC ACID; HOMOARGININE; METHYLGUANIDINE; UREA;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIALYSIS; FEMALE; GLOMERULONEPHRITIS; HUMAN; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UREA BLOOD LEVEL; UREMIA;

EID: 0030801352     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90273-0     Document Type: Article

References (51)

1. Ringoir S, Schoots A, Vanholder R: Uremic toxins. Kidney Int 33:S4-S9, 1988 (suppl)
2. May RC, Mitch WE: Pathophysiology of uremia, in Brenner BM, Rector FC (eds): The Kidney. Philadelphia, PA, Saunders, 1995, pp 2148-2169
3. Giovannetti S, Biagini M, Balestri PL, et al: Uremia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine. Clin Sci 36:445-452, 1969
4. Giovannetti S, Balestri PL, Barsotti G: Methylguanidine in uremia. Arch Intern Med 131:709-717, 1973
5. De Deyn PP, Marescau B, Cuykens JJ, et al: Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency. Clin Chim Acta 167:81-88, 1987
6. Yamamoto Y, Saito A, Manji T, et al: A new automated analytical method for guanidino compounds and their cerebrospinal fluid levels in uremia. Trans Am Soc Artif Internal Organs 24:61-68, 1978
7. De Deyn PP, Marescau B, D'Hooge R, et al: Guanidino compound levels in brain regions of non-dialyzed uremic patients. Neurochem Int 27:227-237, 1995
8. Stein IM, Cohen MD, Kornhauser R: Guanidinosuccinic acid in renal failure, experimental azotemia and inborn errors of the urea cycle. N Engl J Med 280:926-930, 1969
9. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
10. Marescau B, Deshmukh DR, Kockx M, et al: Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. Metabolism 41:526-532, 1992
11. G-methylarginine derivatives in myelin basic protein from developing and mutant mouse brain. Biochem J 287:929-935, 1992
12. Ceriotti G: Ultramicrodetermination of plasma urea by reaction with diacetylmonoxime antipyrine without deproteinization. Clin Chem 17:400-402, 1971
13. Natelson S, Stein I, Bonas JE: Improvements in the method of separation of guanidino amino acids by column chromatography. Isolation and identification of guanidinosuccinic acid from human urine. Microchem J 8:371-382, 1964
14. Cohen BD, Stein IM, Bonas JE: Guanidinosuccinic aciduria in uremia. A possible alternate pathway for urea synthesis. Am J Med 45:63-68, 1968
15. Natelson S, Sherwin JE: Proposed mechanism for urea nitrogen re-utilization: Relationship between urea and proposed guanidine cycles. Clin Chem 25:1343-1344, 1979
16. Marescau B, De Deyn PP, Qureshi IA, et al: The pathobiochemistry of uremia and hyperargininemia further demonstrates a metabolic relationship between urea and guanidinosuccinic acid. Metabolism 41:1021-1024, 1992
17. Menichini GC, Giovannetti S: A new method for measuring guanidine in uremia. Experientia 29:506-507, 1972
18. Nakamure K, Ienaga K, Yokozawa T, et al: Production of methylguanidine from creatinine via creatol by active oxygen species: Analyses of the catabolism in vitro. Nephron 58:42-46, 1991
19. Nagase S, Aoyagi K, Narita M, et al: Active oxygen in methylguanidine synthesis. Nephron 44:299-303, 1986
20. Aoyagi K, Nagase S, Narita M, et al: Role of active oxygen on methylguanidine synthesis in isolated rat hepatocytes. Kidney Int 32:S229-S233, 1987 (suppl)
21. Sasaki M, Takahara K, Natelson S: Urinary guanidinoacetate/ guanidinosuccinate ratio: An indicator of kidney dysfunction. Clin Chem 19:315-321, 1973
22. Tofuku Y, Muramoto H, Kuroda M, et al: Impaired metabolism of guanidinoacetic acid in uremia. Nephron 41:174-178, 1985
23. McGuire DM, Gross MD, Elde RP, et al: Localization of L-arginine-glycine amidinotransferase protein in rat tissues by immuno-fluorescence microscopy. J Histochem Cytochem 34:429-435, 1986
24. Ryan WL, Wells IC: Homocitrulline and homoarginine synthesis from lysine. Science 144:1122-1125, 1964
25. Scott-Emuakpor A, Higgins JV, Kohrman AF: Citrullinemia: A new case, with implications concerning adaptation to defective urea synthesis. Pediatr Res 6:626-633, 1972
26. ∈-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-δ-hydroxylysine from human urine. J Biol Chem 245:5751-5758, 1970
27. Carnegie PR, Fellows FCI, Symington GR: Urinary excretion of methylarginine in human disease. Metabolism 26:531-537, 1977
28. Vallance P, Leone A, Calver A, et al: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575, 1992
29. Lou MF: Human muscular dystrophy: Elevation of urinary dimethylarginines. Science 203:668-670, 1979
30. Levillain O, Marescau B, De Deyn PP: Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy. Kidney Int 47:464-472, 1995
31. Dobbelstein H, Edel HH, Schmidt M, et al: Guanidinbernsteinsäure and Urämie. I. Mitteilung: Klinische Untersuchungen. Klin Wochenschr 49:348-357, 1971
32. Horowitz HI, Cohen BD, Martinez P, et al: Defective ADP-induced platelet factor 3 activation in uremia. Blood 30:331-340, 1967
33. Stein IM, Cohen BD, Horowitz HI: Guanidinosuccinic acid: The "X" factor in uremic bleeding? Clin Res 16:397, 1968 (abstr)
34. Matsumoto M, Mori A: Convulsive activity of methylguanidine in cat and rabbits. IRCS Med Sci 4:65, 1976
35. Jinnai D, Sawai A, Mori A: Guanidinobutyric acid as a convulsive substance. Nature 212:617, 1966
36. Jinnai D, Mori A, Mukawa J, et al: Biochemical and physiological studies on guanidino compounds induced convulsions. Jpn J Brain Physiol 106:3668-3673, 1969
37. Mori A: Biochemistry and neurotoxicology of guanidino compounds. History and recent advances. Pavlov J Biol Sci 22:85-94, 1987
38. Yokoi I, Toma J, Mori A: The effects of homoarginine on the EEG of rats. Neurochem Pathol 2:295-300, 1984
39. De Deyn PP, MacDonald RL: Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. Ann Neurol 28:627-633, 1990
40. D'Hooge R, Pei Y-Q, Marescau B, et al: Convulsive action and toxicity of uremic guanidino compounds: Behavioral assessment and relation to brain concentration in adult mice. J Neurol Sci 112:96-105, 1992
41. Giovannetti S, Cioni L, Balestri PL, et al: Evidence that guanidines and some related compounds cause haemolysis in chronic uremia. Clin Sci 34:141-148, 1968
42. Lonergan ET, Semar M, Terzel RB, et al: Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia. N Engl J Med 284:1399-1403, 1971
43. Minkoff L, Gaertner G, Darab M, et al: Inhibition of brain sodium-potassium ATPase in uremic rats. J Lab Clin Med 80:71-78, 1972
44. Reynolds IJ, Rothermund K: Multiple modes of NMDA receptor regulation by guanidines, in De Deyn PP, Marescau B, Stalon V, et al (eds): Guanidino Compounds in Biology and Medicine. London, UK, Libbey, 1992, pp 441-448
45. Hiramatsu M, Ohba S, Edamatsu R, et al: Effect of guanidino compounds on membrane fluidity of rat synaptosomes, in De Deyn PP, Marescau B, Stalon V, et al (eds): Guanidino Compounds in Biology and Medicine. London, UK, Libbey, 1992, pp 387-393
46. MacAllister RJ, Whitley GSJ, Vallance P: Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int 45:737-742, 1994
47. Rees DD, Palmer RMJ, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 86:3375-3378, 1989
48. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000, 1989
49. Stuehr DJ, Marietta MA: Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-gamma. J Immunol 139:518-525, 1987
50. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-388, 1988
51. D'Hooge R, Raes A, Lebrun P, et al: N-methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: Behavioural and electrophysiological evidence. Neuropharmacology 35:433-440, 1996